TY - JOUR T1 - Higher Perceived Stress during the COVID-19 pandemic increased Menstrual Dysregulation and Menopause Symptoms JF - medRxiv DO - 10.1101/2022.07.30.22278213 SP - 2022.07.30.22278213 AU - Romina Garcia de Leon AU - Alexandra Baaske AU - Arianne Y Albert AU - Amy Booth AU - C. Sarai Racey AU - Shanlea Gordon AU - Laurie W. Smith AU - Anna Gottschlich AU - Manish Sadarangani AU - Angela Kaida AU - Gina S. Ogilvie AU - Lori A. Brotto AU - Liisa A.M. Galea Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/07/31/2022.07.30.22278213.abstract N2 - Purpose The increased stress the globe has experienced with the COVID-19 pandemic has affected mental health, disproportionately affecting women. However, how perceived stress in the first year affected menstrual and menopausal symptoms has not yet been investigated.Methods Residents in British Columbia, Canada, were surveyed online as part of the COVID-19 Rapid Evidence Study of a Provincial Population-Based Cohort for Gender and Sex (RESPPONSE). A subgroup (n=4171) who were assigned female sex at birth (age 25-69) and were surveyed within the first 6-12 months of the pandemic (August 2020-February 2021), prior to the widespread rollout of vaccines, were retrospectively asked if they noticed changes in their menstrual or menopausal symptoms, as well as completing validated measures of stress, depression, and anxiety.Results We found that 27.8% reported menstrual cycle disturbances and 6.7% reported increased menopause symptoms. Those who scored higher on perceived stress, depression, and anxiety scales were more likely to have reproductive cycle disturbances. Free text responses revealed that reasons for disturbances were perceived to be related to the pandemic.Conclusions The COVID-19 pandemic has highlighted the need to research women’s health issues, such as menstruation. Our data indicates that in the first year of the pandemic, almost a third of the menstruating population reported disturbances in their cycle, which is approximately two times higher than in non-pandemic situations and four times higher than any reported changes in menopausal symptoms across that first year of the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this project was from a Michael Smith Foundation for Health Research Grant (19055) and a BC Women's Health Foundation Grant (LRZ30421) both awarded to LAB and GSO. Additional support was provided by CIHR (PJT-148662) awarded to LAMG.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was received from the British Columbia Childrens and Womens Research Ethics board (H2001421). All methods performed as a part of this study were in accordance with the UBC Research Ethics Board guidelines.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData cannot be shared publicly because of ethical restrictions. Data are available from the UBC Research Ethics Board (contact via cwreb{at}bcchr.ubc.ca) for researchers who meet the criteria for access to confidential data. ER -